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Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a chronic disease of cattle
with a detrimental impact on food quality and production. Research on bTB vaccines has
predominantly been focused on proteinaceous antigens. However, mycobacteria have a
thick and intricate lipid outer layer and lipids as well as lipopeptides are important for
immune-evasion and virulence. In humans, lipid extracts of M. tuberculosis have been
shown to elicit immune responses effective against M. tuberculosis in vitro. Chloroform-
methanol extraction (CME) was applied toM. bovis BCG to obtain a hydrophobic antigen
extract (CMEbcg) containing lipids and lipopeptides. CMEbcg stimulated IFN-g+IL-2+ and
IL-17A+IL-22+ polyfunctional T cells and elicited T cell responses with a Th1 and Th17
cytokine release profile in bothM. bovis BCG vaccinated andM. bovis challenged calves.
Lipopeptides were shown to be the immunodominant antigens in CMEbcg, stimulating
CD4 T cells viaMHC class II. CMEbcg expanded T cells killed CMEbcg loaded monocytes
and the CMEbcg-specific CD3 T cell proliferative response following M. bovis BCG
vaccination was the best predictor for reduced pathology following challenge with M.
bovis. Although the high predictive value of CMEbcg-specific immune responses does not
confirm a causal relationship with protection against M. bovis challenge, when taking into
account the in vitro antimycobacterial phenotype of CMEbcg-specific T cells (e.g. Th1/
Th17 cytokine profile), it is indicative that CMEbcg-specific immune responses could play
a functional role in immunity against M. bovis. Based on these findings we conclude that
lipopeptides of M. bovis are potential novel subunit vaccine candidates and that further
studies into the functional characterization of lipopeptide-specific immune responses
together with their role in protection against bovine tuberculosis are warranted.
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Bovine tuberculosis (bTB) has a huge impact on animal and
human health and additional control strategies to curtail the
impact of bTB are needed (1, 2). The global prevalence of bTB is
estimated to be as high as 9% (1) and costs of the disease are
predicted to be $3 billion annually for the cattle industry alone
(3). Mycobacterium bovis is the predominant cause of bTB, but
all members of the Mycobacterium tuberculosis complex are
thought to be able to cause tuberculosis in cattle (4, 5).
Mycobacterium bovis has a broad host range and is an
important zoonotic agent. In spite of the fact that in many
countries the public health risk of bTB has been alleviated by the
pasteurization of milk, M. bovis is estimated to cause 121,000
zoonotic TB cases annually, predominantly in low- and middle-
income countries (2, 6). Mycobacterium bovis shares a 99.95%
sequence identity to M. tuberculosis (5) and the pathogenesis of
bTB is similar to tuberculosis in humans (7). Bovine TB has been
eradicated or is under control in a large number of high-income
countries, following the implementation of disease control
programs based on a test and cull approach in combination
with strict movement controls (8, 9). However, eradication of
bTB has proven difficult in several countries, particularly when
there is spill-over from bTB reservoirs in wildlife (10–12).
Additionally, implementation of test-and-cull programs may
not be socially or economically acceptable, particularly in
many low- and middle-income countries (13, 14). In these
situations, vaccination against M. bovis could be an alternative
control strategy. Bacille Calmette-Guérin (BCG), a live
attenuated strain of M. bovis, has been used as a vaccine since
the 1920’s and, despite decades of research, is still the only
available vaccine against tuberculosis in humans and livestock (1,
15). However, BCG vaccination provides variable protection in
cattle [reviewed by Waters, Palmer (3), Buddle, Vordermeier
(16)] and, importantly, because BCG vaccination interferes with
bTB diagnostics that are based on the use of the tuberculin skin
test (17–19), it is incompatible with most bTB disease control
programs. There is, therefore, an urgent need for novel vaccines
against bTB that do not interfere with routine bTB diagnostics.
Numerous TB vaccine candidates have been tested or are
being developed, including variations upon BCG (different
vaccination regiments, genetic modification), other (attenuated
and/or genetically modified) mycobacteria either live or dead,
and (vectored) sub-unit vaccines [reviewed for cattle by
Vordermeier, Jones (1) and for humans by Khoshnood,
Heidary (15)]. Well-known examples of sub-unit vaccines are
those based on the immunodominant, secreted, protein antigens
Ag85, ESAT6, and CFP10, some of which have been used in
experimental trials in cattle and are in various phases of clinical
trials in humans. Almost all of this research has in common that
it is focused on the use of protein antigens, either because
(secreted) proteins are used as vaccine antigen or because
protein antigens are used as readouts to measure immune
responses following vaccination with whole mycobacteria.
However, mycobacteria have a thick and intricate lipid outer
layer and lipids and lipoproteins play a role in immune-evasion
and virulence (20, 21). Interestingly, these cell wall associatedFrontiers in Immunology | www.frontiersin.org 2hydrophobic molecules have been shown to be potent antigens in
humans. Several lipids of M. tuberculosis are recognized by CD1
restricted T cells (22–26) and a substantial proportion of the M.
tuberculosis-specific T cells in TB infected humans target
lipopeptides and have antimycobacterial effector functions (27,
28). Hydrophobic and cell wall-associated antigens have been
largely overlooked in previous antigen screens for M. bovis and
there is a paucity of data on immunity against lipid antigens in
bTB.VanRhijn,Nguyen (29) showed thatT cells frombTB infected
cattle respond to a lipid extract ofM.bovis andphosphatidylinositol
mannosides, a class of mycobacterial glycolipids, were shown to
elicit an immune response in M. bovis-infected cattle (30).
Exploring non-conventional antigens, such as hydrophobic
lipopeptides and lipids, has several advantages for vaccine design:
i) the potential vaccine antigen repertoire is expanded and
diversified; ii) some hydrophobic antigens have intrinsic adjuvant
properties (e.g. TLR activation by lipopeptides); iii) lipid antigens
can be more conserved because they are not the product of a single
gene and therefore have lower mutation rates; and finally, iv)
current diagnostics of bTB are based on protein antigens or
protein extracts and therefore vaccines based on lipid antigens are
not predicted to interfere with bTB diagnostics.
The aim of the current study was to further our
understanding of immune responses against hydrophobic
antigens in bovine tuberculosis and to identify potential novel
vaccine antigens. T cell responses against hydrophobic antigens
of Mycobacterium bovis BCG were characterized both in BCG
vaccinated and bTB infected animals. We found that
hydrophobic antigens, extracted from BCG using chloroform-
methanol, elicited polyclonal T cell responses in M. bovis
immune animals. Our data suggest that lipopeptides, presented
to CD4+ T cells via MHC class II, were the immunodominant
antigens in this extract and that immune responses against the
hydrophobic antigen extract following BCG vaccination was a
predictor for reduced pathology following M. bovis challenge.MATERIALS AND METHODS
Cattle and Sample Collection
All animals were housed at the Animal and Plant Health Agency
at the time of blood sampling, and procedures were conducted
within the limits of a United Kingdom Home office license under
the Animal (Scientific Procedures) Act 1986, which were
approved by the APHA Animal Welfare and Ethical Review
Body (AWERB) committee.
Twenty-four 6-months old male Holstein-Friesian or Holstein-
Friesian cross calves were acquired from a TB-free herd located in a
non-endemic area and selected fornegative test results for thewhole
blood stimulationIFN-g release assay for aBCG-vaccinationandM.
bovis challenge study. Six calves served as control animals and 18
calveswere vaccinatedwith0.5mlof4.6×106CFUBCGDanishSSI
1331 (Statens SerumInstitute) via the subcutaneous route. In-house
grown BCGDanish SSI 1331, stored frozen in aliquots, was thawed
on the day of vaccination and diluted with 7H9 broth (Becton
Dickinson) with 0.05% Tween 80 (Sigma). The actual vaccination
dose was confirmed retrospectively by culture. Animals wereNovember 2020 | Volume 11 | Article 588180
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weeks following vaccination, all 24 animals were infected with 104
CFU M. bovis AF2122/97 via the endobronchial route. For this
phase, a randomized block designwas appliedwith one control and
three BCG vaccinated animals randomly allocated to one animal
room. The challenge inoculum was prepared from a frozen stock
and the challenge dose was confirmed retrospectively by culture.
The inoculum was administered just before the tracheobronchial-
junction using an endoscope. Eleven weeks postM. bovis challenge
(20 weeks post BCG vaccination) animals were euthanized and
post-mortem examination was performed as described in detail
elsewhere (31). In summary, lungs and lymph-nodes of head and
pulmonary regions were examined for the presence of gross visible
lesions. The severity of the gross pathology of lungs and lymph
nodes were scored using a semi-quantitative scoring system and
combined resulting in a total pathology score (31). Blood samples
were taken at regular intervals to monitor immune responses.
Additional blood samples were obtained from naturally M. bovis-
infected cattle from British herds with known bovine tuberculosis
outbreaks, which were positive for the single intradermal
comparative cervical tuberculin skin test and the whole blood
antigen stimulation IFN-g release assay.
PBMC Isolation and Culture
Peripheral blood mononuclear cells (PBMC) were isolated from
blood by density gradient centrifugation using Histopaque-1077
(Sigma-Aldrich) and cryopreserved or used directly. For antigen
stimulation, PBMCwere seeded in triplicate in 96-well U-bottom
plates at 4 × 105 cells/well in 200 µl cell culture medium (RPMI
1640 containing 25 mM HEPES, 5 × 10−5M b-mercaptoethanol,
100 U/ml penicillin, 100 mg/ml streptomycin, ± 0.1 mMNEAA, 2
mM Glutamine/GlutaMax, all from Gibco Life Technologies,
and 10% fetal calf serum from Sigma) in the presence of relevant
antigens, unless indicated otherwise for specific methods. For all
experiments, cells or blood were incubated at 37°C in 5% CO2.
Antigens and Antibodies
Hydrophobic antigens were extracted fromM. bovis BCGDanish
1331 using a chloroform-methanol extraction method modified
from Layre, Paepe (32). Lyophilized bacteria were resuspended
in PBS and washed twice with PBS by centrifuging (15,000 g,
2 min) and removal of the supernatant. Clean glass pipettes,
borosilicate glassware and PTFE lined caps (all Corning/VWR)
were used for all subsequent procedures involving solvents. The
bacterial cell pellet was resuspended in a 20 times pellet volume
of CHCl3:CH3OH (2:1, v/v) and incubated for 2 h at RT on a
rocker. After centrifugation (4,000 g, 10 min), the liquid phase
was collected and the bacterial pellet was subjected to subsequent
extractions using CHCl3:CH3OH (1:1, v/v) and CHCl3:CH3OH
(1:2, v/v) for 1 h at RT, respectively. The combined supernatant
of all three extracts was centrifuged and the supernatant collected
in a new tube. The extract was subjected to a Folch wash by the
addition of 20% of the total extraction volume of 0.9% NaCl and
vortexing the solution. Following centrifugation the upper phase
(the Folch wash) was removed, the sample centrifuged again, and
the remaining Folch wash was removed. The CHCl3:CH3OH
phase was filtered through a 0.2 µM PTFE filter (Millipore) into aFrontiers in Immunology | www.frontiersin.org 3clean weighed tube. The sample was dried under nitrogen while
heated to 40°C and the dry mass was weighed. The chloroform-
methanol extract of BCG (CMEbcg) was dissolved in CHCl3:
CH3OH (1:1, v/v) at 4 mg/ml and stored at −20/−80°C. Prior to
use in experiments, an aliquot was dried under nitrogen or using
a heating block (40–50°C) only and resuspended in appropriate
media followed by sonication for 10 min in a heated water bath at
37–50°C, brief vortexing, incubation at 50°C for 50 min, brief
vortexing and again 10 min sonication at 37–50°C and used at a
final concentration of 20 µg/ml to stimulate cells. Bovine and
Avian tuberculin purified protein derivative (PPDB and PPDA,
Prionics) were used at a final concentration of 300 IU/ml and 250
IU/ml respectively. Recombinant 6 kDa early secretory antigen
(ESAT6, Lionex) and 10 kDa culture filtrate protein (CFP10,
Lionex) were used at 2.5 µg/ml. A pooled peptide cocktail of
Antigen 85a (Ag85a, Mimotopes) consisting of peptides of 15
amino acids in length overlapping by ten residues was used at 20
µg/ml. Concanavalin A (Sigma) was used at 2.5 µg/ml and PWM
(Sigma) at 10 µg/ml.
The following antibodies were used: anti-CD3 (MM1a), anti-
CD4 (ILA12), anti-CD8 (ILA51), anti-TCRd (GB21a), anti-CD25
(ILA111), anti-CD45-RO (ILA116), anti-CD172a (ILA24), anti-
DRB3 (ILA21), anti-DQ (CC158), anti-CD1b1/3 [bCD1b3 (33)],
IgG2a isotype (Av37) all produced in-house; anti-CD25
(CACT108a), anti-CD4 (CC8), anti-DRB3 (TH14B), and anti-
DQ (TH81A5) from Washington State University Monoclonal
Antibody Center; anti-CD4 (CC30), anti-CD14 (Tük4),
polyclonal goat anti-huIgG F(ab’)2-FITC from Bio-Rad; anti-
CCR7 (3D12) from eBioscience; streptavidin-PE from Biolegend
or BDPharmingen; anti-perforin (dG9) fromBDBiosciences; anti-
granulysin (rabbit polyclonal biotinylated IgG) from Raybiotech;
rabbit polyclonal biotinylated IgG isotype from Abcam; mouse
IgG1 and IgG2a isotype controls and polyclonal goat anti-
muIgG2b-AF633 from ThermoFisher Scientific; anti-boTCRd
(GB21A) and (biotinylated) polyclonal rabbit anti-boIL-17A
(Kingfisher Biotech); recombinant bivalent anti-boIL-22 Fab (34).
For all flow cytometry experiments, antibodies were either directly
conjugated with fluorochromes in house (Pacific Blue™, Alexa
Fluor™ 488, and Alexa Fluor™ 647 antibody labeling kit,
Invitrogen), bought directly conjugated or labeled with isotype-
specificfluorochrome-conjugatedantibodies. Toexclude dead cells,
cells were stained with Fixable Yellow or Violet Dead Cell Stain
(ThermoFisher Scientific) in PBS. Cells were stained at
predetermined optimal antibody concentrations in PBS buffer
supplemented with 2% FCS and 0.01% Azide at 4°C for 15–30
min. The same buffer was used for washing. Samples were acquired
on a LSRFortessa™ (BD Biosciences) or CyAn ADP analyzer
equipped with 405, 488, and 642 nm lasers (Beckman Coulter)
for intracellular flow cytometry. Data were analyzed using FlowJo
software (TreeStar Inc.). Flow cytometry gating strategy is outlined
in Supplemental Figure 1.Two-Dimensional Thin Liquid
Chromatography
The lipid content of CMEbcg was analyzed using two-
dimensional thin liquid chromatography (2D-TLC) accordingNovember 2020 | Volume 11 | Article 588180
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spotted unto aluminum backed silica gel 60 F254 TLC plates
(Fisher Scientific). Plates were dried (10 min 80°C) and placed in
the appropriate direction in equilibrated TLC tanks containing
solvents mixtures as detailed in Table 1. Between each run and
before staining, plates were dried (10 min 80°C). For staining,
plates were sprayed with molybdophosphoric acid (5% in 95%
ethanol, Sigma-Aldrich) and subsequently charred with a hot air
gun. Lipid classes were identified by comparing the staining
pattern to previously published 2D-TLC analyses of
mycobacterial lipid extracts (35, 36).
SDS-PAGE
CMEbcg was dissolved in Laemmli buffer by sonication and
heating as described for medium. Antigens were incubated at
95°C for 5 min in Laemmli buffer. Samples or Precision Plus
Protein Standards (Bio-Rad) were loaded onto a 14% Tris-
Glycine gel (Novex) and run under denaturating conditions.
Proteins were visualized using GelCode™ Blue Safe Protein Stain
(ThermoFisher Scientific).
Proliferation Assays
To measure proliferation, PBMC were stained with CellTrace
Violet at 1.75 µM (Invitrogen) in Hanks Balanced Salt Solution
(Gibco Life Technologies) for 10 min at RT before antigen
stimulation. Staining was quenched by adding cell culture
medium and incubating for 10 min at RT. Cell proliferation
was assessed by flow cytometry as the percentage of CTV low
cells (Supplemental Figure 1). Antigen specific proliferation was
obtained by subtracting medium control values (spontaneous
proliferation) from the antigen stimulation values and are
indicated as D % CTV low.Cytokine Measurements
Five days following stimulation of PBMC with antigen, as
described above, tissue culture plates were centrifuged (300 g
for 10 min) and supernatants were harvested and stored at −80°C
before use. IFN-g was measured using the BOVIGAM ELISA
(Prionics) according to the manufacturer’s instructions, with
addition of a recombinant IFN-g (ThermoFisher Scientific)Frontiers in Immunology | www.frontiersin.org 4standard curve. IL-17A was measured as described for bovine
CXCL10 (37) using polyclonal rabbit anti-boIL-17A (1.25 µg/
ml), biotinylated polyclonal rabbit anti-boIL-17A (1.0 µg/ml),
and recombinant boIL-17A (all from Kingfisher Biotech). IL-22
was measured by an in-house ELISA using recombinant bivalent
anti-boIL-22 HuCAL antibodies (34) and custom polyclonal
anti-boIL-22 antibodies (Abcore). A Multiskan Ascent
(Thermo Labsystems) plate reader was used to measure the
absorbance at 450 nm.
TNF-a, IL-1b, IL-12 and IL-10 were simultaneously detected
using the MSD multiplex platform (Meso Scale Discovery) as
previously described (38). In summary, MSD multiplex 96-well
plates were supplied pre-coated with capture antibodies on
spatially separated locations. Blocking, incubation of samples
or recombinant cytokines, washing, and addition of detection
antibodies were similar to a conventional ELISA. Detection
antibodies were SULFO-TAG™ (Meso Scale Discovery)
labeled and emit light upon electrochemical stimulation
initiated at the electrode surface of the MSD-plates and the
luminescent signal for each cytokine at the defined spatial
locations was measured on a MSD-6000. For IFN-g, TNF-a,
IL-1b, IL-12, and IL-10 samples were measured in duplicate. The
IL-17A and IL-22 ELISA showed a high precision and
reproducibility and samples were measured as singletons.
Duplicate samples of the standard curve were checked for each
ELISA plate to confirm that the variation for each ELISA plate
was low.
Heparinized whole blood samples from the calves in the
BCG-vaccination M. bovis challenge study (1.5 ml in 24-well
plates) were stimulated with PPDA and PPDB within 6 h of
drawing blood and incubated for 20–24 h. Tissue culture plates
were centrifuged (300 g for 10 min) and supernatant harvested
and stored at −80°C before measuring IFN-g by ELISA as
described above, except that DOD PPDB-PPDA values, rather
than IFN-g concentrations, were calculated.
Proteinase K Digestion
Antigens, dissolved or diluted in RPMI as described, were treated
with 400 µg/ml Proteinase K (ThermoFisher Scientific) for
60 min at 50°C in a waterbath. Proteinase K was subsequently
inactivated by denaturating for 10 min at 85°C. For mock
treatment, the proteinase K was denatured before addition to
the samples. An equal amount of cell culture medium with all
additives at double concentration was added and the CMEbcg
antigens were subjected to another round of dissolving in order
to dissolve any lipid antigens that were not dissolved in the
original RPMI only buffer.
Sodium Hydroxide Delipidation
Antigens, dissolved or diluted in RPMI as described, were treated
with 0.12 or 0.22M sodium hydroxide for 30 min at 50°C in a
waterbath, followed by neutralization of the sodium hydroxide
with an equimolar amount of hydrochloric acid to restore the pH
to ~7.2. For mock treatment, sodium hydroxide and
hydrochloric acid were added at equimolar amounts in the first
step. An equal amount of cell culture medium with all additivesTABLE 1 | Solvents for 2D-TLC characterization of mycobacterial lipids.
Solvent
system
Run
direction
Solvents (v) Runs Polarity
A 1 petroleum ether : ethyl acetate (98:2) 3 Apolar
2 petroleum ether : acetone (98:2) 1
C 1 petroleum ether : acetone (92:8) 1
2 toluene : acetone (95:5) 1
D 1 chloroform : methanol : water
(100:14:0.8)
1
2 chloroform : acetone : methanol : water
(50:60:2.5:3)
1
E 1 chloroform : methanol : water (60:30:6) 1 Polar
2 chloroform : acetic acid : methanol : water
(40:25:3:6)
1
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were subjected to another round of dissolving.
Blocking of Antigen Presentation
Antibodies blocking antigen presentation via DR (ILA21,
TH14B), DQ (CC158, TH81A5), and CD1b (bCD1b3) or
relevant isotype control antibodies were added to PBMC and
incubated for 30 min at 37°C 5% CO2 before addition of
antigens. Final antibody concentration was 10 µg/ml.
In Vitro T Cell Expansion
To investigate antigen-specific T cell responses, T cells were
expanded in vitro and re-stimulated with antigens. PBMC were
seeded at 2–3 × 106 cells/ml in 0.5 ml or 1 ml cell culture media
in 48-well or 24-well plates with PPDB, CMEbcg, or Ag85a.
T Cell Activation
To analyze T cell activation following antigen re-stimulation,
PBMC were cultured for 10 days. The medium was partially
replaced and supplemented with 40 IU/ml recombinant human
IL-2 (Chyron) on day 4. On day 6/7 half of the medium was
replaced with normal cell culture medium. T cells were harvested
on day 10, counted and re-stimulated with antigen and irradiated
autologous Theileria annulata-transformed cells (TaA) as
antigen presenting cells (39) at a 1:2 ratio of TaA:T cells. Three
days following re-stimulation CD25 expression and blasting of T
cells (high forward and sideward scatter) was measured by
flow cytometry.
Cytotoxicity Assays
For the cytotoxicity assays, cells were cultured for 13 days and
supplemented with 20 IU/ml IL-2 at day 4 and 7 and the medium
was partially replaced on day 10 and 12. On day 13 T cells were
harvested, counted, and added to CellTrace Violet labeled
autologous monocytes seeded at 3 × 104 cells/well in 96-well
plates in the presence of antigen. Monocytes were isolated from
cryopreserved PBMC by labeling with monoclonal antibody ILA24
followed by isolation using Mouse IgGspecific paramagnetic beads
(Miltenyi) according to the manufacturer’s instruction. Following a
20 h incubation period cells were washed with PBS and put on ice
for 15 min to detach the adherent cells. Cells were then resuspended
by pipetting, washed with PBS, pelleted, and stained with Fixable
Yellow Dead Cell Stain. Precision count beads (1 × 104 beads/well,
BioLegend) were added and the samples analyzed by flow
cytometry. Monocytes were identified as CellTrace Violet positive
cells and the viability dye and the counting beads allowed
enumeration of the percentage and absolute number of live cells
per well. Specific lysis was calculated by expressing the results
relative to the average value for the medium control condition for
all animals according to the following equation: % specific lysis =
(average medium control – sample)/average medium control × 100.
The expression of perforin and granulysin by T cells was also
analyzed on day 13. First, harvested T cells were stained with T cell
phenotyping markers, followed by fixation of the cells in a 2%
formaldehyde buffer and permeabilization using FACS
Permeabilizing Solution 2 (BD bioscience). Intracellular
granulysin and perforin were stained in the presence ofFrontiers in Immunology | www.frontiersin.org 5permeabilizing solution using the mouse-anti-human perforin
mAb dG9 (BD bioscience, isotype included) and polyclonal
biotinylated rabbit anti-bovine granulysin antibodies (Raybiotech,
isotype control from Abcam), respectively, using a two-step
intracellular staining protocol.
Cultured IFN-g/IL-2 FluoroSpot Assay
Cryopreserved PBMC were cultured at 2 × 106 cells/ml in the
presence of 300 IU/ml PPDB or 10 µg/ml CMEbcg. On day 4 and
7 cells were fed with cell culture medium supplemented with
recombinant human IL-2 (Gentaur) at a final concentration of
10 IU/ml. Where necessary, cells were fed again between day 7
and 9. On days 10 and 12, half of the medium was replaced with
IL-2-free medium. Antigen expanded cells were harvested and
washed on day 13 for FluoroSpot assays and intracellular
cytokine staining. Monocytes were isolated from cryopreserved
PBMC using CD14-specific paramagnetic beads (Tük4,
Miltenyi) according to the manufacturer’s instruction and
incubated with 300 IU/ml PPDB or 10 µg/ml CMEbcg at 37°C
and 5% CO2. For the FluoroSpot, monocytes (5 × 10
3/well) were
cultured directly on antibody coated PVDF filter plates
(MultiscreenHTS IP-FL, Merck Millipore, UK) overnight
before adding 1 × 104 day 13 cell blasts to each of the wells
with antigen loaded monocytes. Coating and development of the
IFN-g/IL-2 dual FluoroSpot is described elsewhere (40).
Intracellular IL-17A/IL-22 Staining
Cells were cultured as for the cultured IFN-g/IL-2 FluoroSpot assay.
Day 13 T cells were stimulated with antigen loaded monocytes at a
10:1 T cell:monocyte ratio for 19 h, with the addition of Brefeldin A
at 10 µg/ml for the last 15 h. Extra- and intra-cellular staining was
performed as described previously (34).
Complement Lysis
CellTrace Violet stained PBMC were stained with anti-bovine
CD4 mAb ILA12 or with isotype control Av37 at 3 µg/ml in cell
culture medium for 30 min at RT. Next, freshly prepared and
sterile filtered baby rabbit serum (Bio-Rad) was added to a final
concentration of 10% and cells incubated at 37°C 5% CO2 for
60 min with mixing of the cells every 15 min. Cells were washed
twice with cell culture medium to remove the baby rabbit serum
and cell debris, and were incubated with antigen as described.
Data Analyses and Statistics
Cytokine concentrations were calculated by interpolating from
recombinant cytokine standard curves using a four-parameter
sigmoidal function for non-linear regression curve fitting in
Prism 7 (GraphPad Software). Descriptive and statistical
analyses were performed in Prism or Excel (Microsoft). Where
appropriate medium control values were subtracted from the
antigen stimulation values and this is indicated as D (delta)
response variable. Means are shown in all graphs analyzed,
except when data were analyzed with a non-parametric test in
which case the median is shown. Error bars indicate SEM. The
number of spot forming colonies (SFC) per 103 input cells, was
calculated according to [S × (N/E)]/IR, where Input cell ratioNovember 2020 | Volume 11 | Article 588180
Benedictus et al. Mycobacterial Lipopeptides Elicit Polyfunctional T Cells(IR) is the number of input cells divided by 103; N is the number
of harvested T cells on day 13; E is the number of cells/well in the
FluoroSpot and S is the number of SFC/well, as described by
Vordermeier and Whelan for cultured ELISPOT (41). Where
data is representative for multiple experiments this is indicated in
the figure legends, otherwise data represent a single experiment.
Unpaired data were compared using simple T-tests, whereas
paired data were compared by (one or two-way) repeated measured
ANOVA to account for the pairing across multiple groups (or
paired T test when only two groups were compared). Except for the
antigen presentation blocking data, since the paired difference
following blocking is proportional to baseline values and therefore
a ratio paired T-test was used. In all cases where multiple
comparisons were made within the same graph, p-values were
corrected using the Holm-Šıd́ák method, except for Friedman test
which is a non-parametric test and was followed by Dunn’s method
for multiple comparisons. Comparison of proliferation between the
three groups was analyzed using unpaired two-sided T-tests with
Welch correction for unequal variance, whereas proliferation
between T cell subsets within animals was compared using
repeated measures one-way ANOVA. Cytokine concentrations
were compared to the control animals using unpaired two-sided
T-tests with Welch correction for unequal variance. The effect of
CD4 depletion or mock depletion was compared using paired T-
tests. The effects of Proteinase K and 0.22 M sodium hydroxide
treatment was compared to the respective control treatments using
paired T-tests. Activation of expanded T cells and intracellular
cytokine staining following re-stimulation was compared using two-Frontiers in Immunology | www.frontiersin.org 6way repeated measures ANOVA followed by post-hoc tests to
compare antigen stimulation between CMEbcg and PPDB
expanded T cell populations and compare antigen stimulation to
medium control within T cell populations, respectively. Specific lysis
of monocytes was compared between antigens using a repeated
measures one-way ANOVA. Cultured FluoroSpot cytokine
responses were compared using Friedman test, followed by post-
hoc comparison of antigen stimulation to medium control.
Correlations between total pathology score and immune
parameters were analyzed by Pearson correlation. P-values
corrected for multiple comparisons ≤0.05 were considered
significant. Corrected p-values between 0.05> and ≤0.1 were
considered a trend and are indicated in the figures. *p ≤ 0.05, **p ≤
0.01, ***p ≤ 0.001, ****p ≤ 0.0001.RESULTS
A Hydrophobic Extract of BCG Contains a
Diverse Repertoire of Lipids
Hydrophobic antigens were extracted from the attenuated M.
bovis strain BCG by chloroform-methanol extraction, followed
by a 0.9% NaCl wash to remove any hydrophilic (protein)
contaminants (42). To determine the composition of this
chloroform-methanol extract of BCG (CMEbcg), the lipid
content was characterized by 2D-TLC (Figures 1A–D). Diverse
(glyco)lipids were identified in CMEbcg, including lipids that are
known T cell antigens in cattle, i.e. phosphatidylinositolFIGURE 1 | Characterization of a chloroform-methanol extract of Mycobacterium bovis BCG. (A) Analysis of lipid content of CMEbcg by 2D-TLC followed by
molybdophosphoric acid staining using system A. (B) system C. (C) system D. (D) System E. (E) Comparison of protein content of CMEbcg and PPDB by SDS-
PAGE followed by Coomassie staining. PDIM, apolar phthiocerol dimycocerosates; MQ, menaquinone; TAG, triacyl glycerol; GroMM, glycerol monomycolate; PGL,
phenolic glycolipid; TDM, trehalose dimycolate; GMM, glucose-monomycolate; DPG, diphosphatidyl glycerol; P, phospholipid; PE, phenylethanolamine; PI,
phosphatidylinositol. Several mono- and di-acylated phosphatidylinositol mannosides (PIMs). 1 and 2—running direction TLC.November 2020 | Volume 11 | Article 588180
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of different lipid classes was highly comparable to previously
published 2D-TLC characterizations of chloroform-methanol
extracts of M. bovis (36). To determine whether proteins were
present in CMEbcg, we performed SDS-PAGE followed by
Coomassie staining (Figure 1E). The results were compared to
purified protein derivative of M. bovis (PPDB), a crude protein
extract that is the most widely used antigen extract in TB research
and diagnostics (43). There were no visible protein bands between
10 and 250 kDa for CMEbcg, whereas there was clear staining of
proteins for PPDB. The data presented in Figure 1 confirm that
CMEbcg contains a diverse repertoire of (glyco)lipids and no
detectable proteins.
Hydrophobic Antigens Elicit T Cell
Responses Ex Vivo in BCG-Vaccinated
and M. bovis-Infected Cattle
Since T cells are considered critical in protecting against
mycobacterial infections (3, 44) we addressed whether CMEbcg
elicits T cell responses in M. bovis-immune animals. Peripheral
blood mononuclear cells isolated from cows vaccinated with
BCG or naturally infected with M. bovis were stimulated with
CMEbcg or PPDB. Compared to control animals, there was
significant T cell proliferation in response to CMEbcg
stimulation both in BCG-vaccinated and in M. bovis-infectedFrontiers in Immunology | www.frontiersin.org 7animals (Figure 2A). Comparison of proliferation of CD4, CD8,
and gd T cells from infected animals showed that proliferation
was significantly higher for CD4 T cells than for CD8 and gd T
cells (Figure 2B). Following PPDB stimulation, proliferation
within the total CD3 population was not distinct between groups
(data not shown), but proliferation of CD4 T cells was significantly
higher for BCG-vaccinated andM. bovis-infected animals (Figure
2C). Proliferation of CD4, CD8, and gd T cells from M. bovis-
infected animals was similar to CMEbcg stimulation, with CD4 T
cells showing the strongest response (Figure 2D). Interestingly,
CD4 T cell proliferation following CMEbcg and PPDB stimulation
was comparable in M. bovis infected animals, with averages of 50
and 46% CTV low CD4 T cells, respectively.
To further characterize the immune response elicited by
CMEbcg, we determined cytokine secretion following CMEbcg
stimulation of PBMC (Figures 3A–G). Compared to control
animals, the release of the Th1 associated cytokines IL-12 and
IFN-g tended to be higher or were significantly higher for
vaccinated and M. bovis infected animals. The release of the
pro-inflammatory cytokine IL-1b was significantly higher in
both the BCG vaccinated as well as the M. bovis infected
animals, whereas TNF-a tended to be higher in the M. bovis
infected animals. Interleukin-17A and IL-22, the archetypic
cytokines for Th17 (/Th22) type immune responses, were
significantly higher in both the vaccinates and the infectedA B
DC
FIGURE 2 | T cell responses against a hydrophobic antigen extract of BCG. CellTrace Violet labeled PBMC isolated from control cattle (Control, n = 6), cattle 6
weeks post BCG vaccination (Vaccinates, n = 18), and cattle infected with M. bovis (M. bovis, n = 9) were stimulated with CMEbcg (black) or PPDB (red). After 5
days cells were acquired by flow cytometry to measure proliferation as the fraction of CellTrace Violet (CTV) low cells. (A) CD3 T cell proliferation following stimulation
with CMEbcg. (B, D) Proliferation of different T cell populations in M. bovis infected animals following stimulation with CMEbcg (B) or PPDB (D). (C) CD4 T cell
proliferation following PPDB stimulation. Mean ± SEM is indicated. Unpaired two-sided T-tests with Welch correction (A, C) and repeated measures one-way
ANOVA (B, D), followed by Holm-Šıd́ák correction for multiple comparisons.November 2020 | Volume 11 | Article 588180
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immune regulation, showed no differences between the groups.
The cytokine release profile following PPDB stimulation was
comparable to CMEbcg stimulation (Figures S2A–G). Cytokine
responses following CMEbcg stimulation were higher inM. bovis
infected than in BCG vaccinated animals, except for IL-10, and
this was also seen following PPDB stimulation. Whereas BCG
vaccination leads to a local infection, M. bovis infection is more
widespread and the stronger immune response in M. bovisFrontiers in Immunology | www.frontiersin.org 8infected animals may be the result of both stronger innate
stimulation and antigen exposure. To further characterize the
role of CD4, CD8, and gd T cell subsets in the immune response
against CMEbcg, CMEbcg stimulation was compared following
CD4 T cell depletion of PBMC. Depletion of CD4 T cells
significantly abrogated both T cell proliferation and IFN-g
responses, where the reduction was proportional to the level of
CD4 depletion, confirming the importance of CD4 T cells in the
immune response against CMEbcg (Figure S2H).A B
D
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FIGURE 3 | Hydrophobic BCG antigens elicit strong cytokine responses. CellTrace Violet labelled PBMC isolated from control cattle (Control, n = 6), cattle 6 weeks
post BCG vaccination (Vaccinates, n = 18) and cattle infected with M. bovis (M. bovis, n = 9) were stimulated with CMEbcg. Supernatant was harvested after 5 days
to measure IL-12 (A), IFN-g (B), TNF-a (C), IL-1b (D), IL-17A (E), IL-22 (F), IL-10 (G) cytokine production by ELISA. Mean ± SEM is indicated. Unpaired two-sided
T-tests with Welch correction, followed by Holm-Šıd́ák correction for multiple comparisons.November 2020 | Volume 11 | Article 588180
Benedictus et al. Mycobacterial Lipopeptides Elicit Polyfunctional T CellsSummarizing these results, CMEbcg elicits T cell responses
with a Th1 and Th17 cytokine release profile that has been
associated with protection against bovine tuberculosis in
previous studies (45–48).
Lipopeptides Are the Immunodominant
Antigens in CMEbcg
Having assessed the biochemical composition of CMEbcg and
verified its immunogenicity, we next sought to determine the
biochemical nature of the immunogenic fractions. CMEbcg and
PPDB were treated with proteinase K or sodium hydroxide to
degrade all proteins/peptides or lipids, respectively, and the effect of
these treatments on T cell stimulation was assessed. Degrading
proteinaceous antigen components abrogated CD4 T cell
proliferation following both CMEbcg and PPDB stimulation
(Figures 4A, D). This was expected for the crude protein extract
PPDB, but was surprising for CMEbcg as this extract contains
various antigenic lipids, but has a very low protein content.
However, delipidation also abrogated the immunogenicity of
CMEbcg (Figure 4B). As expected, delipidation had no effect on
the immunogenicity of PPDB (Figure 4E). The effects of proteinFrontiers in Immunology | www.frontiersin.org 9degradation and delipidation on the stimulation of other T cell
subsets was comparable to the effects on CD4 T cell stimulation
(Figure S3). In humans, lipopeptides have been identified as the
immunodominant antigens in hydrophobic extracts of M.
tuberculosis (27, 28). The above results show that both protein/
peptide and lipid components present inCMEbcg are important for
its immunogenicity, indicating that lipopeptides are also the
immunodominant antigens inCMEbcg forM.bovis immune cattle.
Lipopeptides contain protein as well as lipid domains that
could potentially be presented to T cells via classical MHC and
CD1, respectively. The role of these different antigen presenting
molecules in presenting antigens to CMEbcg-specific T cells was
assessed by testing blocking by antibodies specific for MHC class
II and CD1b. Blocking MHC class II presentation almost
completely abolished CD4 T cell stimulation by CMEbcg,
whereas blocking of CD1b had no blocking effect (Figure 4C).
Blocking of MHC class II presentation also abrogated CD4 T cell
responses against PPDB (Figure 4F). Whereas individual T cells
will be restricted to a single antigen presenting molecule,
blocking of either DRB or DQ almost completely inhibited T
cell activation, both for PPDB and CMEbcg. This is a commonA B
D E F
C
FIGURE 4 | Characterization of the immunodominant antigens in CMEbcg. PBMC from M. bovis infected animals (n = 4) (A, B, D, E) or BCG vaccinated animals
(n = 4) (C, F) were stimulated with normal, mock, or enzymatically/chemically treated CMEbcg at 20 µg/ml (A–C) or PPDB at 300 IU/ml (D–F). After 5 days CD4 T
cell proliferation was measured as the percentage of CellTrace Violet low cells. (A, D) Proteinaceous antigens were digested with Proteinase K. (B, E) Antigens were
delipidated by sodium hydroxide treatment. (C, F) PBMC were preincubated with blocking monoclonal antibodies against MHC class II (DRB3 and DQ) or CD1b at
10 µg/ml. Mean ± SEM is indicated. All data are representative for two separate experiments. Paired T-test (A, B, D, E). Ratio paired T-test, followed by Holm-Šıd́ák
correction for multiple comparisons (C, F).November 2020 | Volume 11 | Article 588180
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lines (27, 28, 49–51). These blocking experiments showed that
lipopeptides in CMEbcg are presented to CD4 T cells via MHC
class II.
Antigen-Specific Expansion of
Polyfunctional T Cells Following
CMEbcg Stimulation
Potential novel vaccine antigens have to induce antigen-specific
memory. Stimulation of PBMC directly ex vivo predominantly
detects activation of effector T cells, whereas re-stimulation of
cultured (antigen expanded) T cells allows interrogation of the
memory T cells response (41, 52, 53). To confirm that T cell
expansion and activation in response to CMEbcg is antigen-
specific, we established short term T cell cultures using either
CMEbcg or PPDB for primary T cell expansion. Expanded T
cells were re-stimulated with CMEbcg, PPDB, and Ag85a, using
CD25 expression as a marker to measure T cell activation
(Figure 5). In CMEbcg expanded T cells CD25 upregulation
was highest following CMEbcg re-stimulation, followed by PPDB
re-stimulation, whilst Ag85a re-stimulation was no higher than
observed in the unstimulated (media only) control (Figures 5A,
B). Conversely, re-stimulation of the PPDB expanded T cell lines
with PPDB resulted in the highest level of CD25 expression. The
preferential activation of expanded T cells following stimulation
with their cognate antigens demonstrates that CMEbcg and
PPDB have different antigenic composition and that the T cell
expansion observed is antigen-specific. The lower level of T cell
stimulation observed with the reciprocal antigen extracts is most
likely due to non-proteinaceous antigens within the PPDB
extract. Proteomic analysis has shown that lipopeptides are
present in PPDB (54, 55), implying that there is a degree of
commonality in non-protein antigens. However, the substantial
disparity in the responses induced by Ag85a stimulation of the
CMEbcg and PPDB expanded lines from an Ag85a-responding
animal confirms critical differences in the antigenic specificity of
responses elicited by CMEbcg and PPDB (Figure 5A).Frontiers in Immunology | www.frontiersin.org 10The ability of T cells to directly kill and/or inhibit the growth
of intracellular M. bovis (and of M. bovis infected cells) and to
produce cytokines have both been associated with
immunological protection against bovine tuberculosis (7, 45,
47, 56, 57). To examine the potential functionality of CMEbcg-
expanded T cells, we performed a number of assays to describe
their functional phenotype. Firstly, we assessed the expression of
perforin and granulysin, anti-mycobacterial effector molecules of
the cytotoxic pathway (58–60). Following CMEbcg stimulation,
perforin expression was upregulated in CD8 T cells and
granulysin expression was upregulated in both CD8 and CD4
T cells (Figure 6A, Figure S4). To explore whether CMEbcg-
specific T cells are cytotoxic, killing of autologous antigen-loaded
monocytes by expanded T cells was analyzed by flow cytometry
(Figure 6B). Compared to co-incubation without antigen,
loading monocytes with CMEbcg significantly increased the
killing of monocytes by CMEbcg expanded T cells. CMEbcg-
expanded T cells also killed PPDB loaded monocytes. Similar
results were found for PPDB-expanded T cells, where significant
increased killing of monocytes was seen both for PPDB and
CMEbcg antigen loading, with a tendency for a higher killing of
PPDB loaded than CMEbcg loaded monocytes (p = 0.052).
Similar to the re-stimulation assays, the ability of CMEbcg and
PPDB-expanded T-cell populations to recognize monocytes
loaded with the reciprocal extract indicates that the two
extracts shared common antigenic components. Antigen
loading without the addition of cultured T cells had no effect
on monocyte viability (data not shown), excluding a direct
cytotoxic effect of the antigen extracts.
We examined the cytokine responses of CMEbcg expanded
memory T cells by intracellular IL-17A and IL-22 staining and
cultured IFN-g and IL-2 FluoroSpot (Figures 6C, D), focusing
on cytokines that have been associated with protection in M.
bovis vaccination-challenge experiments (45–48, 57). Overall
two-way repeated measures ANOVA indicated that there was a
significant effect of re-stimulation of CMEbcg-expanded T cells
with PPDB or CMEbcg on the number of IL-17A (p = 0.046) andA B
FIGURE 5 | Preferential activation of expanded T cells by cognate antigens. Short term T cell cultures were set up by stimulating PBMC from BCG vaccinated
animals (n = 4) with CMEbcg or PPDB. On day 10, expanded T cells were re-stimulated with CMEbcg, Ag85a, or PPDB and autologous Theileria annulata cells as
antigen presenting cells. On day 13 T cell activation was measured as percentage of CD25 high cells. Comparison of antigen-specific T cell activation of CMEbcg or
PPDB expanded T cells for a single animal (A) and between four animals (B). Mean ± SEM is indicated. Data are representative for two separate experiments. Two-
way repeated measures ANOVA followed by Holm-Šıd́ák correction for multiple comparisons of antigen stimulation between CMEbcg and PPDB expanded T cell
populations (B).November 2020 | Volume 11 | Article 588180
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FIGURE 6 | Characterization of CMEbcg and PPDB expanded T cells. PBMC from BCG vaccinated animals were stimulated with CMEbcg or PPDB and cultured
for 13 days. (A) Perforin and granulysin expression measured by flow cytometry on day 13 post CMEbcg stimulation. Isotype control, shaded area. Perforin/
Granulysin staining, dashed line. (B) Killing of antigen loaded monocytes by antigen expanded T cells (n = 4). CellTrace Violet stained monocytes were cultured with
antigen expanded T cells at an effector:target ratio of 20:1 with or without antigen. After a 20 h incubation period, monocyte viability was measured by flow
cytometry. Data are representative for two separate experiments. (C) Intracellular cytokine staining for IL-17A and IL-22, 19 h after re-stimulation of CMEbcg
expanded T cells (n = 6) with antigen loaded monocytes. Cells were co-stained for CD4 and gamma delta T cell (gd) markers. (D) Cultured IFN-g and IL-2 FluoroSpot
of CMEbcg expanded T cells (n = 6) stimulated with antigen loaded monocytes for 20–22 h. Numbers of total IFN-g, IL-2 (single and dual secreting), or dual IFN-g/IL-
2 secreting cells are shown. Mean ± SEM is indicated in (B, C), median in (D). Repeated measures one-way ANOVA followed by Holm-Šıd́ák correction for multiple
comparisons (A). Two-way repeated measures ANOVA followed by Holm-Šıd́ák correction for multiple comparisons of antigen stimulation to medium control within
T cell populations (C). Friedman test, followed by Dunn’s method for multiple comparisons (D).Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 58818011
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different T cell populations, the percentage of positive cells was
highest within CD4 T cells and was slightly higher following
PPDB re-stimulation compared to CMEbcg. Total IL-17A+IL-
22+ cells were significantly higher following CMEbcg (p = 0.019)
and PPDB (p = 0.019) restimulation (Friedman test followed by
Dunn’s method for multiple comparisons) and polyfunctional
IL-17A+IL-22+ cells were predominantly CD4 T cells (Figure
6C). The number of IFN-g secreting cells, measured by
FluoroSpot, was significantly higher following CMEbcg and
PPDB re-stimulation of CMEbcg-expanded T cells (Figure
6D). For IL-2, there was a significant increase in the number
of secreting cells following both CMEbcg or PPDB re-
stimulation. Almost all IL-2-positive secreting cells were
polyfunctional, also secreting IFN-g (Figure 6D). As a
comparison and control, we also looked at the cytokine
responses of PPDB-expanded T cells. As expected, PPDB-
expanded cultured T cells also produced IL-17A, IL-22, IFN-g,
and IL-2 (Figure S5). For IL-2, IFN-g, and IL17A the fraction of
positive cells was higher following re-stimulation of PPDB-
expanded T cells compared to CMEbcg-expanded T cells.
Notably, the opposite was the case for IL-22+ and IL-17A+IL-
22+ cells, where the fraction was higher in the CMEbcg expanded
T cells.
Overall, these experiments show that CMEbcg-specific
cultured T cells, which are indicative for a central memory T
cell pool, have functional characteristics that are associated with
protection against M. bovis disease.
CMEbcg-Specific T Cell Proliferation Post
BCG Vaccination Was the Best Predictor
for Protection Against M. bovis Challenge
In order to examine the relevance of immune responses against
hydrophobic antigens, CMEbcg-specific T cell responses were
measured longitudinally in calves enrolled in a BCG vaccination
andM. bovis challenge study (Figure 7). A week following BCG-
vaccination CMEbcg-specific T cell responses could be detected,
measured as CD4 T cell proliferation and IFN-g secretion
following ex vivo stimulation of PBMC (Figure 7A). Total and
CD4 T cell proliferation peaked at week 3, whereas IFN-g
responses peaked at 8 weeks post vaccination. In contrast there
were no changes in the immune response against CMEbcg in the
control animals, except for a transient rise in CD3 T cell
proliferation in week 1. Nine weeks after BCG vaccination,
both control and vaccinated animals were challenged
endobronchially with a virulent strain of M. bovis. M. bovis
challenge induced CMEbcg-specific immune responses in the
unvaccinated animals, with responses detectable at 2 weeks post
infection and rising until 8 weeks post infection. In the BCG
vaccinated animals, challenge boosted CMEbcg-specific immune
responses and responses were higher than following vaccination.
Longitudinal responses to PPDB (Figure 7B) were comparable
to those described for CD4 T cells following CMEbcg
stimulation. Except for one difference, the CMEbcg-specific
responses following challenge were similar for vaccinated and
unvaccinated calves at the final timepoint, whereas for PPDB theFrontiers in Immunology | www.frontiersin.org 12response was higher in the unvaccinated than the vaccinated
animals. Proliferation of CD8 and gd T cells was comparable to
CD4 T cell responses (Figure S6). Altogether, both BCG
vaccination and M. bovis infection rapidly induced a robust
immune response against CMEbcg.
Next, we analyzed whether immune responses post BCG
vaccination, but before M. bovis challenge, correlated with
protection against bovine tuberculosis. Protection was defined
as a reduction in the severity of M. bovis associated lesions in
lung and lymph nodes assessed 11 weeks post challenge at post
mortem examination. T cell proliferation and IFN-g release
following stimulation with CMEbcg and PPDB were selected as
potential indicators of immunity. Ranking the correlations
between the BCG-vaccination-induced immune parameters
before challenge and the pathology score following M. bovis
infection showed that only CMEbcg-specific T cell proliferation
correlated significantly with challenge outcome (Table 2).
CMEbcg-specific T cell proliferation showed a significant and
negative association with pathology followingM. bovis challenge
(Figure 7C). In this vaccination and challenge study, T cell
responses against the hydrophobic antigen extract CMEbcg in
BCG-vaccinated animals were associated with protection against
pathology resulting from M. bovis challenge.DISCUSSION
Additional as well as alternative control strategies are needed to
curtail the impact of bovine tuberculosis on animal and human
health (1, 2). Here we assessed the potential of hydrophobic
mycobacterial antigens as novel vaccine candidates against
bovine tuberculosis in cattle. A hydrophobic antigen extract of
M. bovis BCG elicited strong T cell responses in M. bovis
immune cattle and lipopeptides were shown to be the
immunodominant antigens. Immune responses to hydrophobic
mycobacterial antigens post BCG vaccination correlated with
protection against experimental M. bovis challenge. This study
underlines the potential of mycobacterial lipopeptides as targets
for further research and candidates for novel subunit vaccines
against bovine tuberculosis.
Research on vaccines forM. bovis has focused on proteinaceous
antigens, despite the fact that mycobacteria possess a thick
hydrophobic outer layer consisting of (glyco)lipids, lipoproteins,
and hydrophobic proteins that are involved in interaction with the
host. We found that CMEbcg, a hydrophobic antigen extract ofM.
bovis BCG, elicited robust T cell responses in cattle following BCG
vaccination and following both natural and experimentalM. bovis
infection. Chemical and enzymatic degradation indicated that
lipopeptides are the immunodominant antigens in CMEbcg.
These findings are in line with studies demonstrating lipopeptides
to be the immunodominant hydrophobic antigens in M.
tuberculosis infected humans (27, 28) as well as in BCG
vaccinated guinea pigs (61). The M. bovis genome encodes for
approximately a hundred lipoproteins shown to be important for
bacterial homeostasis as well as virulence, playing a role in
pathogen-host interaction and immune modulation (20, 62–64).November 2020 | Volume 11 | Article 588180
Benedictus et al. Mycobacterial Lipopeptides Elicit Polyfunctional T CellsDisrupting the lipidation process of lipoprotein precursors resulted
in attenuation of M. tuberculosis in vitro and in vivo (64) and
knockout of individual lipoproteins ofM. bovis orM. tuberculosis
can also result in attenuation in vivo (65–67).Frontiers in Immunology | www.frontiersin.org 13Post-translational modification of lipoprotein precursors
occurs by the sequential action of the three enzymes Lgt, LspA,
and Lnt. Following recognition of a conserved lipobox motif in
the signal peptide, the prelipoprotein is first diacylated, then theA B
C
FIGURE 7 | Longitudinal characterization of immune responses against CMEbcg and PPDB in BCG vaccinated and M. bovis challenged calves. Six-month-old male
Holstein-Frisian cross calves (n = 18) were vaccinated subcutaneously with 4.6 × 106 CFU BCG Danish SSI 1331. Six calves served as controls. In week 9 (dotted
line) all animals (n = 24) were challenged endobronchially with 104 CFU M. bovis AF2122/97. PBMC were stimulated for 5 days with CMEbcg (A) or PPDB (B) and
proliferation was measured by flow cytometry as the percentage of CellTrace Violet low cells and supernatant was harvested to measure IFN-g release by ELISA.
Mean ± SEM is indicated. (C) Correlation between CMEbcg-specific T-cell proliferation 8 weeks post BCG vaccination and gross pathology score 11 weeks after
M. bovis challenge within BCG vaccinated calves (n = 18). Pathology scores were based on the macroscopic identification of lesions in lymph nodes and lung tissue
at post-mortem examination (31).November 2020 | Volume 11 | Article 588180
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attached. BCG has been shown to use palmitic and
tuberculostearic acid as substrates for acylation (62). Because
of the lipid and peptide composition of lipopeptides these
antigens could potentially be recognized by CD1-restricted
lipid-reactive T cells and by conventional MHC-restricted
peptide-reactive T cells. Blocking of MHC class II presentation
almost completely abolished T cell activation, showing that
recognition of the peptide components by MHC class II restricted
T cells is the predominant route for T cell stimulation. Together
with the strong proliferative and cytokine responses in CD4 T cells
and the effect of CD4 T cell depletion on overall T cell activation
followingCMEbcg stimulation, these data showthatCD4Tcells are
the main population responding to lipopeptides. Depletion of CD4
T cells also abrogated CD8 and gd T cell proliferation, suggesting
bystander activation of these populations. However, depleting CD4
Tcells also abrogates the secretionof growth factors (e.g. IL-2) and it
is unknownwhether the observedCD8 and gdT cell responses are a
result of bystander activation or cognate antigen stimulation.
There are only two other studies that examined the
immunogenicity of hydrophobic mycobacterial antigens in the
context of bovine tuberculosis. Van Rhijn, Nguyen (29) found
that stimulation of PBMC from M. bovis infected cattle with
hydrophobic M. bovis antigens elicited T cell proliferation.
Although they used a chloroform-methanol extraction method
similar to the method described here, protease treatment of the
hydrophobic antigen extracts did not affect T cell stimulation
and they therefore concluded that l ipids were the
immunodominant antigens in the hydrophobic antigen extract.
This is in contrast to our findings that protein degradation
almost completely abrogated T cell activation. Compared to
their extraction method, we included a Folch wash at the end
of the extraction process to remove any hydrophilic (protein)
contaminants (42), making the extraction more stringent.
Differences in M. bovis growth conditions, the extraction
method, and in T cell assays complicate a comparison of both
studies. However, our finding that lipopeptides, rather than
lipids, are the immunodominant hydrophobic antigens are in
line with studies in humans (27, 28) and guinea pigs (61). Pirson,
Engel (30) demonstrated that phosphatidylinositol mannosidesFrontiers in Immunology | www.frontiersin.org 14(PIMs), a class of mycobacterial glycolipids, activated T cells
from M. bovis infected cattle. CMEbcg contained several lipid
antigens, including PIMs, glucose monomycolate (GMM), and
glycerol monomycolate (GroMM). The glycolipid GMM was
discovered as an immunodominant lipid T cell antigen in cattle
infected with Mycobacterium avium subspecies paratuberculosis
(29), whereas GroMM is an immunogenic T cell antigen in
human tuberculosis (22). In humans, almost all lipid T cell
antigens of M. tuberculosis, including GroMM and the PIMs,
are presented via CD1b or CD1c (68). While cattle do not have
CD1c, they do express CD1b (69) and GMM was shown to be
presented to T cells via CD1b (29). Interestingly, while the assay
condition used here have shown to be conducive to study (CD1b
mediated) lipid antigen presentation (29, 30), blocking of CD1b
did not block T cell stimulation by CMEbcg. Together with the
importance of MHC class II presentation and in line with
findings in TB infected humans (27, 28), this indicates that
although lipid-reactive T cells have been found in cattle they are
not as numerous as lipopeptide-reactive T cells.
Stimulation with CMEbcg elicited T cell activation expressly
in immune animals and led to expansion of antigen-specific T
cells, demonstrating that BCG vaccination induces a robust
lipopeptide (CMEbcg) specific T cell memory. Although the
immune response to CMEbcg was shown to be antigen-
specific, CMEbcg-expanded T cells also strongly responded to
PPDB re-stimulation and vice versa for PPDB-expanded T cells,
indicating there is antigen overlap between the two extracts. This
cross reactivity of CMEbcg-expanded T cells to PPDB was also
demonstrated in humans (27) and guinea pigs (61). Mass
spectrometry analyses of PPDB identified several lipopeptides
(54, 55), also indicating antigen overlap between the extracts.
Individual immunogenic lipoproteins of M. bovis have
previously been identified in cattle, e.g. MPB83 (70), LpqH
(71), LpqE and LpqD (72). The protein domain of lipoproteins
can be quite large (e.g. 500 amino acids for LpqL), but proteins
staining of CMEbcg loaded SDS-PAGE gels did not detect any
proteins. This suggests that hydrophobic N-terminal lipidated
protein fragments (lipopeptides), rather than full lipoproteins,
are eluted into the chloroform-methanol solvent and determine
the antigenicity of CMEbcg. Only a single known T cell epitope
towards the N-terminus of a lipoprotein of M. bovis is registered
on the Immune Epitope Database (73), but this is on a total of
only seven known epitopes from just two studies in cattle (71,
72). Numerous epitopes towards the N-terminus of lipoproteins
of M. bovis and M. tuberculosis have been identified in other
species (61, 74). Lipopeptides were recognized by MHC class II
restricted T cells and this leaves the question why delipidation
nevertheless abrogated T cell activation. There are several
explanations of how lipidation of proteins might influence T
cell activation: stimulation of APCs through activation of pattern
recognition receptors (20, 75), unmasking or modification of
epitopes by the lipidation process (76), improved antigen uptake,
processing, and presentation of intact lipopeptides (77–79). The
intrinsic adjuvant properties of lipopeptides, potentially leading
to improved antigen processing and T cell stimulation, make
lipopeptides interesting vaccine candidates. Indeed syntheticTABLE 2 | Correlations between immune responses post BCG vaccination and
pathology following M. bovis challenge.
Immune response post BCG vaccination
Antigen Immune parameter Pearson R 95% C.I. p-value1
CMEbcg CD3 T cell proliferation −0.66 −0.86 to −0.27 0.013
PPDB CD3 T cell proliferation −0.54 −0.80 to −0.09 0.063
CMEbcg IFN-g release −0.43 −0.75 to 0.04 0.141
PPDB IFN-g release −0.14 −0.57 to 0.35 0.590Pearson correlation between selected immune parameters 8 weeks post BCG vaccination
and pathology scores at post mortem 11 weeks after M. bovis challenge within BCG
vaccinated calves (n =18). Calves were vaccinated with BCG and challenged with M. bovis
as described in Figure 7. Immune parameters, shown in Figure 7, were log transformed.
Pathology scores were based on the macroscopic identification of lesions in lymph nodes
and lung tissue at post-mortem examination. 1 p-values adjusted for multiple comparisons
using the Holm-Šıd́ák method and p-values ≤ 0.05 are in bold.November 2020 | Volume 11 | Article 588180
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(80) and can confer protection in murine vaccination-M.
tuberculosis challenge models (81, 82). The only example of
vaccination against a lipoprotein in cattle was with a plasmid
DNA expressing only the protein part of the lipoprotein MPB83.
Although in infected cattle MPB83 is an immunodominant
lipoprotein, vaccination with an experimental DNA vaccine
encoding the protein part of MPB83 induced limited T cell
responses and did not protect against M. bovis challenge (83). In
contrast, vaccination of mice with recombinant MBT83, the M.
tuberculosis orthologue of MPB83, conjugated to a lipid moiety
did confer protection against M. tuberculosis challenge (84).
Indicating that lipidation of the protein is important for
inducting protective immunity.
In the current study, T cell proliferation, specific to the
lipopeptide-containing extract, following BCG vaccination was
the best predictor for protection against pathology induced by
subsequent M. bovis challenge. The immunogenicity of
hydrophobic mycobacterial antigens and lipopeptides has
been described in other species, but this is the first study
identifying lipopeptide-specific immune responses as a
correlate of protection against pathology induced by a
tuberculosis-causing Mycobacterium species. Ex vivo immune
responses against PPDB can be poor correlates of vaccine
efficacy (48, 85, 86), similar to the results shown in this study.
Several correlates of vaccine efficacy for bovine tuberculosis
have been described in cattle, of which M. bovis antigen-
specific memory T cell responses are particularly promising
[reviewed by Vordermeier, Jones (1)]. We demonstrated that
CMEbcg stimulation elicits robust lipopeptide (CMEbcg)
specific memory T cells that produce IFN-g, IL-17A, and IL-
22. These Th1 and Th17 associated cytokines are associated
with protection against bovine tuberculosis (45–48).
It has been hypothesized that the immunogenicity of
lipoproteins (and of other immunodominant antigens) may
aid mycobacteria by skewing the host immune response
towards a non-protective response or a response that
contributes to persistence (61, 87). Additionally, lipoproteins
can have immunostimulatory or immunosuppressive effects
(20). However the results presented here, i.e. secretion of Th1
and Th17 cytokines and cytotoxic activity of the lipopeptide-
specific T cells and their association with protection against
pathology following experimental challenge, together with the
successful lipoprotein vaccination in murine tuberculosis
models (e.g. 84, 88, 89), argue against this hypothesis.
Protective immunity following vaccination depends on the
target antigens and on the quality of the induced immune
response. To further address the potential of lipopeptides as
vaccine antigens it is important to elucidate whether immune
responses to lipopeptides are causally correlated with protection
againstM. bovis infection and if this is the case, to delineate the
importance of antigen versus quality of the immune response.
That is, whether immunity against specific lipoproteins is
important and hampers the pathogenesis of M. bovis or
whether unique immunogenic properties of lipoproteins orFrontiers in Immunology | www.frontiersin.org 15BCG infection induces protective antimycobacterial immunity
resulting in protection against disease. Detailed characterization
of immune responses to individual lipopeptide antigens will
form a first step in addressing these questions.CONCLUSION
Lipopeptides of M. bovis are highly immunogenic in cattle,
i nduc ing robu s t memory T ce l l r e s pon s e s w i t h
antimycobacterial phenotypes, including secretion of key Th1
and Th17 associated cytokines. This is the first study showing
that immune responses to hydrophobic mycobacterial antigens
post BCG vaccination correlate with protection against
experimental M. bovis challenge, emphasizing the potential of
mycobacterial lipopeptides as targets for novel subunit vaccines
against bovine tuberculosis.DATA AVAILABILITY STATEMENT
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